List of excluded studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

Characterization of purified esAEVs based on protein content and the localization of Mif on the surface. by Safia A. Essien (20108379)

A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity by Cheng Deng (416051)

GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

Co-expression analysis of differentially expressed genes. by Quyuan Tao (12261798)

SF pretreatment inhibited the I/R induced decrease in the IRL thickness. by Hong Pan (8686)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Non-covalent lasso entanglements in native and misfolded proteins. by Yang Jiang (46459)

Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue by Elisabeth G. Hain (542261)

“…Such alterations can be measured by magnetic resonance elastography (MRE) as a non-invasive technique to determine viscoelastic parameters of the brain. …”

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…Data are expressed as a mean fold change ± standard error of the mean (SEM) (<i>n</i> = 6), compared to healthy controls (<i>n</i> = 6). …”

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”

Induction of a VSG synthesis block leads to a decrease in clearance of surface-bound anti-VSG221 antibodies. by Jackie L. Y. Cheung (3365033)

Decrease of viral load and ALT at different time points under treatment according to NS5A-inhibitors and interferon administration. by Valeria Cento (103603)

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

The functional half-life of WNV decreases in the presence of virus-specific antibody. by Kimberly A. Dowd (129927)

DA receptor agonist pramipexole reduces generosity reference-point (V). by Sergio Oroz Artigas (8207559)

Mesothelin expression and RG7787 uptake is decreased in KLM-1-R. by Kevin Hollevoet (710450)

“…<p><b>A</b>: Surface mesothelin levels are 5-fold lower in resistant KLM-1 (KLM-1-R) compared to KLM-1. …”

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

5-fold validation results for model training with sex-specific data. by M. Mendez (6624953)

Decreased Rab10 localization in raft fractions following methamphetamine treatment. by Scott M. Vanderwerf (785324)